Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZOTA HEALTH CARE vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ZOTA HEALTH CARE   TEVA PHARMA
EQUITY SHARE DATA
    ZOTA HEALTH CARE
Mar-23
TEVA PHARMA
Dec-13
ZOTA HEALTH CARE/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3783,481-   
Low Rs2253,024-   
Sales per share (Unadj.) Rs55.61,997.6-  
Earnings per share (Unadj.) Rs-2.3124.8-  
Cash flow per share (Unadj.) Rs2.5286.3-  
Dividends per share (Unadj.) Rs1.00109.24-  
Avg Dividend yield %0.33.4 9.9%  
Book value per share (Unadj.) Rs31.92,219.0-  
Shares outstanding (eoy) m25.16848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.41.6 332.9%   
Avg P/E ratio x-131.326.1 -503.9%  
P/CF ratio (eoy) x122.611.4 1,079.0%  
Price / Book Value ratio x9.41.5 643.7%  
Dividend payout %-43.687.5 -49.8%   
Avg Mkt Cap Rs m7,5812,757,874 0.3%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m1210-   
Avg. sales/employee Rs Th037,690.2-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,354.5-  
INCOME DATA
Net Sales Rs m1,3991,693,984 0.1%  
Other income Rs m260-   
Total revenues Rs m1,4251,693,984 0.1%   
Gross profit Rs m72463,899 0.0%  
Depreciation Rs m120136,926 0.1%   
Interest Rs m2633,273 0.1%   
Profit before tax Rs m-47293,700 -0.0%   
Minority Interest Rs m01,334 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,798 -0.0%   
Tax Rs m11-3,586 -0.3%   
Profit after tax Rs m-58105,822 -0.1%  
Gross profit margin %5.227.4 18.8%  
Effective tax rate %-23.1-1.2 1,888.7%   
Net profit margin %-4.16.2 -66.1%  
BALANCE SHEET DATA
Current assets Rs m8421,144,111 0.1%   
Current liabilities Rs m405997,761 0.0%   
Net working cap to sales %31.28.6 361.2%  
Current ratio x2.11.1 181.2%  
Inventory Days Days2091 22.0%  
Debtors Days Days72696 757.2%  
Net fixed assets Rs m728553,293 0.1%   
Share capital Rs m2524,170 6.0%   
"Free" reserves Rs m5520-   
Net worth Rs m8041,881,695 0.0%   
Long term debt Rs m0866,172 0.0%   
Total assets Rs m1,5703,871,297 0.0%  
Interest coverage x-0.89.8 -8.4%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.90.4 203.6%   
Return on assets %-2.03.6 -56.9%  
Return on equity %-7.25.6 -127.7%  
Return on capital %-2.64.9 -53.7%  
Exports to sales %14.00-   
Imports to sales %00-   
Net fx Rs m1930-   
CASH FLOW
From Operations Rs m-20269,933 -0.0%  
From Investments Rs m147-95,648 -0.2%  
From Financial Activity Rs m-139-323,803 0.0%  
Net Cashflow Rs m-12-149,518 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.39 Rs / USD

Compare ZOTA HEALTH CARE With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare ZOTA HEALTH CARE With: FABINO LIFE   BDH INDUS.  VINEET LABORATORIES  COLINZ LABOR  J.B.CHEMICALS  



Today's Market

Gland Pharma Receives USFDA Approval | Maruti Suzuki Crosses Rs 8 Trillion Mark | Top Buzzing Stocks Today Gland Pharma Receives USFDA Approval | Maruti Suzuki Crosses Rs 8 Trillion Mark | Top Buzzing Stocks Today(Pre-Open)

Indian share markets continued the momentum as the session progressed and ended on firm footing.